Docosahexaenoic acid acts as QT-shortening agent with genotype-specific beneficial effects in transgenic LQT1, LQT2, LQT5 and LQT2-5 rabbit models

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Best Posters 1 - Best Posters in ventricular arrythmias and SCD Drug Treatment of Ventricular Arrhythmias ESC Premium Access ESC Congress 2018

About the speaker

4 More presentations in this session

Presentation thumbnail
Professor K. Rizas (Munich, DE)
Presentation thumbnail
Doctor R. Scorza (Stockholm, SE)
Presentation thumbnail
Professor H. Huikuri (Oulu, FI)

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in

ESC 365 is supported by

ESC 365 is supported by